Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

ClinicalTrials.gov ID: NCT00445146

Public ClinicalTrials.gov record NCT00445146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this study is to observe the long-term safety of elvitegravir (EVG) boosted with ritonavir (RTV) in combination with other antiretroviral (ARV) agents in participants who have completed a prior EVG+RTV treatment study.

Study identification

NCT ID
NCT00445146
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
192 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2007 (Type not available)
Primary completion
Mar 2015 (Actual)
Completion
Mar 2015 (Actual)
Last update posted
Apr 25, 2016

2007 – 2015

United States locations

U.S. sites
47
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
Not listed Pheonix Arizona 85006 —
Not listed Little Rock Arkansas 72207 —
Not listed Beverly Hills California 90211 —
Not listed Costa Mesa California 92626 —
Not listed Fountain Valley California 92708 —
Not listed Long Beach California 90813 —
Not listed Los Angeles California 90033 —
Not listed Newport Beach California 92663 —
Not listed Palo Alto California 94305 —
Not listed San Diego California 92103 —
Not listed San Francisco California 94110 —
Not listed Norwalk Connecticut 06851 —
Not listed Washington D.C. District of Columbia 20037 —
Not listed Atlantis Florida 33462 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Manors Florida 33305 —
Not listed Miami Florida 33136 —
Not listed North Miami Beach Florida 33169 —
Not listed North Palm Beach Florida 33408 —
Not listed Orlando Florida 32803 —
Not listed Sarasota Florida 34239 —
Not listed Tampa Florida 33602 —
Not listed Decatur Georgia 30033 —
Not listed Macon Georgia 31201 —
Not listed Chicago Illinois 60657 —
Not listed Baltimore Maryland 21205 —
Not listed Boston Massachusetts 02215 —
Not listed West Springfield Massachusetts 01107 —
Not listed Saint Louis Michigan 63108 —
Not listed Henderson Nevada 89074 —
Not listed Hillsborough New Jersey 08844 —
Not listed Santa Fe New Mexico 87505 —
Not listed Albany New York 12208 —
Not listed Manhasset New York 11030 —
Not listed New York New York 10016 —
Not listed Stony Brook New York 11794 —
Not listed The Bronx New York 11030 —
Not listed Durham North Carolina 27110 —
Not listed Huntersville North Carolina 28078 —
Not listed Hershey Pennsylvania 17033 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Memphis Tennessee 38105 —
Not listed Dallas Texas 75204 —
Not listed Houston Texas 77030 —
Not listed Annandale Virginia 22003 —
Not listed Seattle Washington 98101 —
Not listed Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00445146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00445146 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →